Pharmaceutical

The potential of 3D printing in drug development and delivery

3D printing is replacing traditional prototype development approaches across various industries, and use in healthcare is increasing fast.

Jul 26, 2024 - 04:00
The potential of 3D printing in drug development and delivery
3D printing is replacing traditional prototype development approaches across various industries, and use in healthcare is increasing fast.
Read the original article

Tags:

Previous Article

BioAtla receives FDA fast track designation for ozuriftamab vedotin

Next Article

RSV Antibody Passes Final Trials in Win for Merck

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Biologics emerge as dominating molecule type in solid tumour indication

Biologics emerge as dominating molecule type in solid t...

Oct 7, 2023

House Republicans demand career scientist explain pathogen research

House Republicans demand career scientist explain patho...

May 31, 2023

STAT+: Pharmalittle: PBMs are targeted in yet another congressional bill; access to new Alzheimer’s drug may not happen quickly

STAT+: Pharmalittle: PBMs are targeted in yet another c...

Jun 16, 2023